ESS Results Are In: Shorts Pull Back as Analysts Trim Again
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Essex Property Trust reported third-quarter results today, and the first market reaction is a modest short-covering move after bears had built their largest position in over a year heading into the print.
Short interest fell 0.9% on October 27 to 3.76% of the free float, the first meaningful pullback after a week in which positions had climbed 2.5%. That one-day reduction comes directly after the report, suggesting at least some bears are taking profits. The absolute level is still elevated relative to recent history: shorts are up roughly 5.7% over the past month, so the position has not unwound in any significant way. The lending market remains extremely loose. Availability has actually expanded this week, reaching 2,114% on October 27, up from 1,930% a day earlier and well above the 52-week low of 1,015%. At that level, there are more than twenty shares available to borrow for every one already shorted. Borrowing costs have drifted lower, down 14% over the week to 0.43%, a rate so low it places essentially no friction on new short positions. Options positioning is mildly cautious: the put/call ratio of 0.39 sits about 0.9 standard deviations above its 20-day average of 0.35, though it is nowhere near the 52-week high of 0.90. Taken together, this is a positioning picture where bears were present but never particularly aggressive, and where the borrow market gave them no reason to rush.
The analyst community has been moving in one direction for weeks, and that continued on earnings day itself. Stifel cut its price target to $285.50 from $292.75 this morning while keeping its Hold rating, the latest in a string of reductions that included Wells Fargo (to $279 from $297), UBS (to $275 from $286), Barclays (to $285 from $297), RBC Capital (to $298 from $312) and Piper Sandler (to $326 from $352) over the preceding two weeks. The mean target now sits at $297.11, about 8% above the current price of $274.85. Bulls point to a West Coast portfolio where NorCal is recovering, structured finance headwinds fading after 2026, and a Q1 print where core FFO beat estimates and April leasing spreads jumped. Bears flag the concentration of risk in Los Angeles, where the market has been slow to recover, and the difficulty of driving further environmental compliance gains across more than 62,000 units. The dividend factor score of 84 is the standout in the factor rankings, reflecting the income appeal that keeps generalist buyers engaged even as growth expectations moderate.
Retail attention, as measured by Wikipedia page views, has spiked sharply around the earnings event, with a z-score of 2.63 against the prior 90 days as of October 22. That is colour rather than a directional signal, but it confirms the print is drawing more attention than usual.
Peers had a mixed session. UDR fell 0.25% on the day and CPT dropped 0.47%, while MAA and INVH both declined, the latter by 1.2%. ELS was the notable laggard, down 2.6%. ESS's 0.16% dip looks contained relative to the group, though the week as a whole was positive at just over 1%.
The next scheduled earnings event is not until February 2, 2027, so attention now turns to whether the analyst target-cutting cycle has run its course after today's Stifel reduction, and whether the short position that built through October begins to unwind more decisively or stabilises at its current elevated level.
Stocks in this article
See the live data behind this article on ORTEX.
Open ESS on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 18:13
- Data as of
- 28 Oct 2026, 18:06
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.